sftd

New Diabetes Drug Combo, Duetact™: Combines Pioglitazone and Glimepiride

Filed in archive Treatment on August 20, 2006

New Diabetes Drug Combo, Duetactâ„¢: Combines Pioglitazone and Glimepiride
The new diabetes drug combo recently approved by the USFDA called Duetact™ is a combination of two common diabetes drugs - pioglitazone (sold as Actos®) and glimepiride (sold as Amaryl®) - into a once-daily pill.

Takeda Pharmaceuticals North America, the maker of Duetactâ„¢, plans to make the drug available by prescription later this year, which is to be taken orally once daily with the first main meal of the day.

Duetactâ„¢ (pdf file) will come in three different strengths, each with different proportions of pioglitazone and glimepiride.

The two active ingredients (pioglitazone and glimepiride) both lower blood sugar but works diffrently.

Pioglitazone targets insulin resistance while glimepiride boosts the pancreas' insulin production.

Read more at WebMD.

Permalink: New Diabetes Drug Combo, Duetact™: Combines Pioglitazone and Glimepiride

Tags: diabetes  drug  pioglitazone  glimepiride  duetactâ„¢  diabetes+drug  drug+combo  pioglitazone+g 

Vote for New Diabetes Drug Combo, Duetact™: Combines Pioglitazone and Glimepiride:

  • Currently 10.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 10.00 out of 3 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Allergies   Alzheimer's Disease   Arthritis   Bacteria and Bacterial Infections   Best of   Blog Carnivals   Bone Health   Cancer   Cardiovascular Health   Cases   CFS   Consumer Alert   Controversies   Dental Health   Diabetes   Diagnostics   Diarrhea   Did you know   Diet   Dietary Supplements and Vitamins